<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Michael Barrowman | MyKo101</title>
    <link>/author/michael-barrowman/</link>
      <atom:link href="/author/michael-barrowman/index.xml" rel="self" type="application/rss+xml" />
    <description>Michael Barrowman</description>
    <generator>Source Themes Academic (https://sourcethemes.com/academic/)</generator><language>en-us</language><copyright>Michael Barrowman Â© 2020</copyright><lastBuildDate>Wed, 31 Jul 2019 00:00:00 +0000</lastBuildDate>
    <image>
      <url>/images/icon_hufb6089c2dae8ab059339a50c00192ccd_27937_512x512_fill_lanczos_center_2.png</url>
      <title>Michael Barrowman</title>
      <link>/author/michael-barrowman/</link>
    </image>
    
    <item>
      <title>How unmeasured confounding in a competing risks setting can affect treatment effect estimates in observational studies</title>
      <link>/publication/barrowman-2019a/</link>
      <pubDate>Wed, 31 Jul 2019 00:00:00 +0000</pubDate>
      <guid>/publication/barrowman-2019a/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Study investigating the generalisability of a COPD trial based in primary care (Salford Lung Study) and the presence of a Hawthorne effect</title>
      <link>/publication/pate-2018a/</link>
      <pubDate>Thu, 25 Oct 2018 00:00:00 +0000</pubDate>
      <guid>/publication/pate-2018a/</guid>
      <description></description>
    </item>
    
  </channel>
</rss>
